Study detail
RecruitingPhase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis
InventisBio Co., Ltd
Summary
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Description
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants with Moderate to Severe Plaque Psoriasis
Eligibility
- Age range
- 18–70 years
- Sex
- All
- Healthy volunteers
- No
Detailed criteria